SCHEMBL27042004

SCHEMBL27042004

Cc1cc([N+](=O)[O-])cnc1-c1ncccn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.45
▸ HTT P42858 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ TDP1 Q9NUW8 2/20 0.42
▸ TSHR P16473 2/20 0.42
▸ CRHR1 P34998 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ GPR35 Q9HC97 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ GALR2 O43603 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ MPI P34949 1/20 0.37
▸ CCR6 P51684 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30759891 1.00 ALDH1A1 (0.45) ALDH1A1HTTGAATDP1TSHR
SCHEMBL27042269 0.81 ALDH1A1 (0.46) ALDH1A1HTTTDP1KDM4EMEN1
SCHEMBL31501735 0.81 ALDH1A1 (0.46) ALDH1A1HTTTDP1KDM4EMEN1
SCHEMBL27042365 0.80 PKM (0.46) ALDH1A1HTTTDP1MEN1KMT2A
SCHEMBL31501755 0.80 PKM (0.46) ALDH1A1HTTTDP1MEN1KMT2A
SCHEMBL2404162 0.79 ALDH1A1 (0.53) ALDH1A1HTTGAATDP1TSHR
SCHEMBL31501778 0.76 ALDH1A1 (0.55) ALDH1A1HTTTDP1KDM4EMEN1
SCHEMBL27042252 0.76 ALDH1A1 (0.55) ALDH1A1HTTTDP1KDM4EMEN1
SCHEMBL4711982 0.75 ALDH1A1 (0.47) ALDH1A1HTTGAATDP1TSHR
SCHEMBL29606539 0.74 ALDH1A1 (0.50) ALDH1A1HTTGAATDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260049085-A1 CYCLIC COMPOUNDS AND METHODS OF USING SAME SCHRÖDINGER, INC. (US) 2026-02-19 — — US disclosed
EP-4558505-A2 CYCLIC COMPOUNDS AND METHODS OF USING SAME Schrödinger, Inc. (US) 2025-05-28 — — EP disclosed
WO-2024020534-A2 CYCLIC COMPOUNDS AND METHODS OF USING SAME SCHRÖDINGER, INC. (US) 2024-01-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049085-A1 CYCLIC COMPOUNDS AND METHODS OF USING SAME CCR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, MALT1 ALDH1A1 2214/4885HTT 2638/4885GAA 4271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback